COMMUNIQUÉS West-GlobeNewswire

Biohit Oyj’s Financial Reporting and Annual General Meeting in 2018

08/12/2017 - 15:00

Biohit Oyj Financial calendar, December 8, 2017 at 4:00 pm local time (EET) Biohit Oyj will release its financial statements for 2017 on Wednesday 28 th of February 2018 at 9:30 am. The Annual Report, which contains the [...]

Asklepion Pharmaceuticals Presents Phase 1b/2a Clinical Trial Data for IV-Citrulline at the Pediatric Cardiac Intensive Care Society 13th Annual International Meeting

08/12/2017 - 15:00

BALTIMORE, Dec. 08, 2017 (GLOBE NEWSWIRE) -- Asklepion Pharmaceuticals, LLC (“Asklepion” or “the Company”), a biotechnology company focused on the development of IV-citrulline for rare pediatric diseases, announced [...]

Cancer Genetics Prices $7 Million Registered Direct Offering

08/12/2017 - 14:58

RUTHERFORD, N.J., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX ), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today announced the pricing of a [...]

Fennec Announces Pricing of Public Offering

08/12/2017 - 14:54

RESEARCH TRIANGLE PARK, N.C., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC ) (TSX: FRX ), a biotechnology company focused on the development of PEDMARK TM (a unique formulation of sodium [...]

Marrone Bio Innovations Announces the Availability of Amplitude™ Biofungicide for White Mold Control in the 2018 Growing Season

08/12/2017 - 14:30

DAVIS, Calif., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based pest management and plant health products for agriculture, turf and ornamental and [...]

TG Therapeutics, Inc. Recaps Data Presentations at the Upcoming 59th American Society of Hematology Annual Meeting

08/12/2017 - 14:06

NEW YORK, Dec. 08, 2017 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX ), today recapped the schedule of data presentations for the Company’s lead compounds, TGR-1202, (umbralisib), the Company's once-daily [...]

Allscripts hits record-breaking 1 billion API data shares in a single year

08/12/2017 - 14:01

CHICAGO, Dec. 08, 2017 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ) continues to lead the industry in innovation, interoperability, data sharing, and connectivity as it hits an industry leading milestone of one [...]

Aeterna Zentaris Announces Departure of Interim Chief Financial Officer

08/12/2017 - 14:00

CHARLESTON, S.C., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS ) (TSX: AEZS ) (the “Company”) announced today the departure of the Company’s Interim Chief Financial Officer, Jeffrey Whitnell, [...]

Soleno Therapeutics Announces Joint Venture Agreement for Development and Commercialization of CoSense Monitoring Technology

08/12/2017 - 14:00

REDWOOD CITY, Calif., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ: SLNO ), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today [...]

Wellness Center USA, Inc. Bolsters Corporate Management and Board Membership

08/12/2017 - 14:00

HOFFMAN ESTATES, IL , Dec. 08, 2017 (GLOBE NEWSWIRE) -- Wellness Center USA, Inc. (OTCQB: WCUI ), today announced the appointments of Mr. Paul D. Jones as the Company’s President, Thomas E. Scott, CPA, as the Company’s [...]

Aphios Pharma Raising Equity Capital to Develop FDA-Approved, Cannabis-Based Drug for Opioid Addiction

08/12/2017 - 14:00

WOBURN, Mass., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Aphios ® Pharma today announced plans to raise equity capital from investors to develop an FDA-approved, cannabis-based drug for treating opioid addiction, a highly unmet [...]

Stemline Therapeutics Announces Four SL-401 Presentations at Upcoming ASH Meeting

08/12/2017 - 13:00

NEW YORK, Dec. 08, 2017 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML ), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers, announced today that SL- [...]

SteadyMed Announces FDA Agreed Pathway to Trevyent NDA Resubmission

08/12/2017 - 12:55

SAN RAMON, Calif., Dec. 08, 2017 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq: STDY ), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with [...]

Nicotinamide Riboside Shown to Improve Mitochondrial Energy Production and Memory in Alzheimer’s Disease Research

08/12/2017 - 12:30

IRVINE, Calif., Dec. 08, 2017 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ: CDXC ), a science-based, fully integrated nutraceutical company devoted to extending human healthspan, announced today that in research [...]

OraSure Technologies Announces 2018 Annual Meeting Date

08/12/2017 - 12:00

BETHLEHEM, Pa., Dec. 08, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR ) today announced that its 2018 Annual Meeting of Stockholders is scheduled to be held at 10:00 a.m. EDT (7:00 a.m. PDT) on [...]

Veritas Hires Medical Director to Advise Physicians & Regulators on the Application of Cannevert’s Experimental Results with Cannabis to Clinical Practice & Public Policy

08/12/2017 - 09:05

VANCOUVER, British Columbia, Dec. 08, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) , (“Veritas” or the “Company”) is pleased to announce the hiring of Dr. M. Scott Alexander as [...]

ERYTECH Reports Top-line Results of Phase 2b Study of Eryaspase for the Treatment of AML

08/12/2017 - 09:02

ERYTECH Reports Top-line Results of Phase 2b Study of Eryaspase for the Treatment of AML Conference call and webcast to take place Monday, December 11th at 10:00 a.m. EST LYON, France - December 8, 2017 - ERYTECH Pharma [...]

Photocure ASA: Landmark Blue Light Cystoscopy with Cysview® study is published in the Journal of Urology

08/12/2017 - 08:20

Oslo, Norway, December 8, 2017: Photocure ASA (Photocure, PHO: OSE), today announced that the official Journal of the American Urologic Association (AUA), the Journal of Urology, published the BLFCC Efficacy results [...]

Patient Enrolment in Phase II CIRCLE Study Evaluating THR-409 (ocriplasmin) for Non-Proliferative Diabetic Retinopathy (NPDR) Discontinued due to Slow Recruitment Rate

08/12/2017 - 07:30

Resources redirected to progress new drug candidates to clinic in H1 2018 Press release Leuven, Belgium, 8 December 2017 - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel medicines [...]